Targeting Inflammation in Both ALS and Alzheimer's Disease
Mark Albers, MD, PhD, from Massachusetts General Hospital, discovered a new mechanism that damages nerve cells and triggers an inflammatory response in both ALS and Alzheimer's patients.
Mark W. Albers is a neurologist specializing in memory and olfactory disorders. He earned a PhD in organic chemistry from Harvard University, working in the laboratory of Stuart Schreiber, and an MD degree from the H.S.T. program of Harvard Medical School and M.I.T. He was an internal medicine resident for two years at Massachusetts General Hospital and then trained in neurology at Mass General, and Brigham and Women's Hospital, where he was one of the first chief residents for the Mass General Brigham neurology residency program. Following clinical training, he resumed basic research studies in the laboratory of Richard Axel and practiced behavioral neurology in the Memory Disorders Center at the Neurological Institute, affiliated with Columbia University. Following this training, he returned to Mass General where he sees outpatients in the Memory Disorders Unit and attends on the inpatient neurologic wards. His clinical research is focused on devising sensitive probes of olfactory function as a possible biomarker for early neurodegenerative disease and directly converting olfactory neuronal precursor cells from the nose into brain neurons to develop cell-based models of neurologic disease. He is a member of the Translational Neuroscience committee of the American Academy of Neurology.
Clinical Interests:
Treats:
Mass General Neurology
55 Fruit St.
Boston, MA 02114
Phone: 855-644-6387
Medical Education
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
The goal of the research in the Albers lab is to elucidate the pathogenic actions and physiological functions of genes implicated in neurodegenerative disease.
Read more about the Albers Lab.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
The Mukerji Lab for Neuroinfectious Diseases has an ongoing clinical trial for people with HIV and depression.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
The McCance Center for Brain Health has embraced a radically new approach to preventing brain disease and promoting brain health across the lifespan.
Mark Albers, MD, PhD, from Massachusetts General Hospital, discovered a new mechanism that damages nerve cells and triggers an inflammatory response in both ALS and Alzheimer's patients.
Mark Albers, MD, PhD, is developing a set of simple but powerful tools to screen for the very earliest stages of preclinical Alzheimer’s Disease.
A team at Massachusetts General Hospital and Harvard Medical School has developed an artificial intelligence–based method to screen currently available medications as possible treatments for Alzheimer’s disease.
Mark Albers, MD, PhD, from Massachusetts General Hospital, discovered a new mechanism that damages nerve cells and triggers an inflammatory response in both ALS and Alzheimer's patients.
Mark Albers, MD, PhD, is developing a set of simple but powerful tools to screen for the very earliest stages of preclinical Alzheimer’s Disease.
A team at Massachusetts General Hospital and Harvard Medical School has developed an artificial intelligence–based method to screen currently available medications as possible treatments for Alzheimer’s disease.
Mark Albers, MD, PhD, from Massachusetts General Hospital, discovered a new mechanism that damages nerve cells and triggers an inflammatory response in both ALS and Alzheimer's patients.
Dr mark albers is so so special, he came out to the waiting room to personally greet me/ he was always focused on me and my needs= he is awesome
Dr. Albers was wonderful. My husband and I really appreciate the care and attention he gave us. He answered all our questions, reviewed my history and concerns carefully, explained the lecanemab program and its possible side effects, and made very helpful suggestions on options for me to consider going forward re my mild cognitive impairment. We ... Read More
He was very prepared,knowledgeable,able to answer our questions in a way we could understand
excellent
Doctor was patient and made me feel very comfortable in a very uncomfortable situation.
Stayed late to accommodate my timing. Very knowledgeable.
Dr. Albers was very clear and very responsible to my questions and I think he listened carefully and I very much appreciated being able to talk to him.
Have more specific plans or help
He was very knowledgeable and also compassionate
Dr. Albers was outstanding! He took the time to read a memory history we sent prior to the appointment. At the appointment, he was very knowledgeable, thorough, attentive to our concerns and questions, and was respectful and kind. His treatment plan took into account all of our concerns and left us with a sense of confidence that we are in good ... Read More